NCT04941378 OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer Status WITHDRAWN Phase PHASE1
NCT04939701 Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants Status TERMINATED Phase PHASE1/PHASE2
NCT04931342 A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04921527 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer Status RECRUITING Phase PHASE3
NCT04918186 Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer Status RECRUITING Phase PHASE2
NCT04913337 Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04911114 Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian Cancer Status UNKNOWN Phase NA
NCT04908787 A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer Status COMPLETED Phase PHASE3
NCT04891185 Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer Status TERMINATED Phase PHASE2
NCT04881045 Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. Status COMPLETED Phase PHASE1
NCT04878094 A Study of Intra-operative Imaging in Women With Ovarian Cancer Status RECRUITING Phase PHASE3
NCT04875806 A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04853017 A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors Status COMPLETED Phase PHASE1
NCT04849858 Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures Status TERMINATED Phase PHASE3
NCT04847063 Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies Status RECRUITING Phase PHASE1
NCT04830709 Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer Status RECRUITING Phase N/A
NCT04828616 Study of DP303c Injection in Patients With Advanced Ovarian Cancer Status UNKNOWN Phase PHASE2